Analyzing Active Portfolio Ideas: Antitrust, Asset Sales, Arbitrage, and Litigation Opportunities
VIZIO faces antitrust concerns with Walmart acquisition; FTC scrutiny and potential challenges could impact deal closure and stock price.
46 Views
Key Updates on EPIX, HLVX, PRKR, BOOM, VZIO, WOW, AVAP:L, LOGC, LFCR, DK
Essa Pharma (EPIX) halted pipeline development, launched strategic review, offering 21% upside to NAV/liquidation value by mid-2025.
140 Views
SSI Newsletter Highlights: Merger Arbitrage, Strategic Reviews, and Activist Investor Developments
Embracer Group faces a 20%-50% conglomerate discount, with potential catalysts including spinoffs and increased LOTR franchise awareness.
18 Views
No more insights